Categories

Share:

New Corporate Brochure

February 17, 2020

To make your choice easier and faster 4bases’ company and product information are gathered in the new brochure

Share:

Categories

More Posts

4bases’paper of The Month – February 2024 – Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

TP53, the gene encoding the p53 protein, stands out as the most frequently mutated gene in cancers, affecting approximately 50% of patients. While the normal

4bases’paper of The Month – January 2024 – Benchmarking and improving the performance of variant-calling pipelines with RecallME

In the realm of DNA sequencing, both next-generation sequencing (NGS) and third-generation sequencing (TGS) have revolutionized genomics. While NGS dominates current research and clinical applications,

4bases’ paper of The Month – December 2023 – CFTR pharmacological modulators: a great advance in cystic fibrosis management

Cystic Fibrosis (CF) is an inherited disease, typically affecting the lungs, pancreas, liver, skin, and urogenital tract due to mutations in the cystic fibrosis transmembrane

4bases’paper of The Month – November 2023 -Genetic testing and counseling in the management of cardiomyopathy

The European Society of Cardiology presented its new guidelines for the management of cardiomyopathies. They aim to assist healthcare professionals in the accurate diagnosis and

Powered by Lifency SA © 2025